PVLA
PALVELLA THERAPEUTICS, INC.
Revenue
$520.0K
Net Profit
N/A
ABSI
Absci Corp
$650.0K
$-29.6M
DNTH
Dianthus Therapeutics, Inc.
$284.0K
$-64.4M
ATXG
ADDENTAX GROUP CORP.
$975.8K
$-4.2M
VIR
Vir Biotechnology, Inc.
$240.0K
$-163.1M
PRME
Prime Medicine, Inc.
$838.0K
$-46.1M
MGTX
MeiraGTx Holdings plc
$410.0K
$-50.5M
SLS
SELLAS Life Sciences Group, Inc.
$79.0K
$-9.6M
